IP Library Granted Patent US 10,711,307
Granted Patent B2
US 10,711,307 · App. 15/501,761 · Granted Jul 14, 2020

Method for determining state of differentiation of stem cells, and novel differentiation marker used therefor

Inventor: Yukinobu Hayashida (Amagasaki, JP)
Assignee: FUJIFILM WAKO PURE CHEMICAL CORPORATION
C12Q1/6881C07K14/4702C12N15/09G01N33/50G01N33/5073G01N33/68C12Q2600/156C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,711,307
App. No.
15/501,761
Granted
Jul 14, 2020
Kind
B2
Abstract

The invention relates to a method which is capable of determining, at an initial stage of differentiation, the differentiated state of undifferentiated stem cells. The invention provides a method for determining a differentiated state of a cell comprising detecting expression of FOXB2 gene of a stem cell, and determining the differentiated state based on the result, and a differentiation marker selected from mRNA or protein derived from the FOXB2 gene. The invention is applicable to quality management of the stem cells or to methods for preparation and isolation of the differentiated cells. Further, because the differentiated cells can be determined at an initial stage of culture, the invention is useful for an early stage screening of cells and for quality management of the stem cells, and reduction in culturing period and cost reduction in expenditure regarding a culture medium, or the like, can be expected.

Claims (32)

1. A method for preparing differentiated stem cells comprising:

(a) subjecting undifferentiated stem cells to differentiation-inducing treatment,

(b) detecting an expression of FOXB2 gene in the stem cells, and

(c) isolating the stem cells in which the expression of FOXB2 gene is detected.

2. The method according to claim 1 , wherein the detecting of expression of FOXB2 gene is carried out by detecting FOXB2 mRNA.

3. The method according to claim 1 , wherein the detecting of expression of FOXB2 gene is carried out by detecting FOXB2 protein.

4. The method according to claim 2 , wherein the FOXB2 mRNA is selected from the group consisting of:

(1) mRNA having a nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 34,

(2) mRNA having a nucleotide sequence which has a sequence homology of 97% or more to the nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 34,

(3) mRNA encoding an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35,

(4) mRNA encoding an amino acid sequence in which 1-3 amino acids in the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35 are deleted, inserted, substituted, or added, and

(5) mRNA encoding an amino acid sequence which has a sequence homology of 97% or more to the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35.

5. The method according to claim 3 , wherein the FOXB2 protein is selected from the group consisting of:

(1) a protein having an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35,

(2) a protein having an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35 in which 1-3 amino acids are deleted, inserted, substituted, or added, and

(3) a protein having an amino acid sequence which has a sequence homology of 97% or more to the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35.

6. The method according to claim 2 , wherein the detecting of FOXB2 mRNA is carried out by an RT-PCR method.

7. The method according to claim 1 , wherein the undifferentiated stem cells are iPS cells or ES cells.

8. The method according to claim 1 , wherein an amount of expression of FOXB2 gene in the stem cells is detected, the detected amount of expression of FOXB2 gene in the stem cells is compared to a detected amount of the expression of FOXB2 gene in control stem cells that have been confirmed to be in an undifferentiated state, and the stem cells in which the detected amount of expression of FOXB2 gene is greater than the detected amount of expression of FOXB2 gene in the control stem cells are isolated.

9. The method according to claim 8 , wherein the detecting of an amount of expression of FOXB2 gene is carried out by detecting an amount of FOXB2 mRNA and the comparing of the detected amount of FOXB2 gene is carried out by comparing the detected amount of FOXB2 mRNA.

10. The method according to claim 9 , wherein the FOXB2 mRNA is selected from the group consisting of:

(1) mRNA having a nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 34,

(2) mRNA having a nucleotide sequence which has a sequence homology of 97% or more to the nucleotide sequence shown in SEQ ID NO: 1 or SEQ ID NO: 34,

(3) mRNA encoding an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35,

(4) mRNA encoding an amino acid sequence in which 1-3 amino acids in the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35 are deleted, inserted, substituted, or added, and

(5) mRNA encoding an amino acid sequence which has a sequence homology of 97% or more to the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35.

11. The method according to claim 8 , wherein the detecting of an amount of expression of FOXB2 gene is carried out by detecting an amount of FOXB2 protein and the comparing of the detected amount of FOXB2 gene is carried out by comparing the detected amount of FOXB2 protein.

12. The method according to claim 11 , wherein the FOXB2 protein is selected from the group consisting of:

(1) a protein having an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35,

(2) a protein having an amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35 in which 1-3 amino acids are deleted, inserted, substituted, or added, and

(3) a protein having an amino acid sequence which has a sequence homology of 97% or more to the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO: 35.

13. The method according to claim 8 , wherein the undifferentiated stem cells are iPS cells or ES cells.

Assignments (2)
CHANGE OF NAME Recorded Jun 13, 2018
From: WAKO PURE CHEMICAL INDUSTRIES, LTD.
To: FUJIFILM WAKO PURE CHEMICAL CORPORATION
Reel/Frame 046075/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2017
From: HAYASHIDA, YUKINOBU
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.
Reel/Frame 041173/0190 →
Priority Claims (1)
JP 2014-167800 · Aug 20, 2014 · national
Continuity (1)
Related Publication 20170342490A1 · Nov 30, 2017